83 related articles for article (PubMed ID: 26680816)
21. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
22. Infusional 5-Fluorouracil, Leucovorin and Docetaxel in Advanced Gastric Cancer.
Kim YT; Sohn JH; Kim SH; Rha SY; Kim C; Roh JK; Kim BS; Jang WI; Chung HC
Cancer Res Treat; 2003 Apr; 35(2):123-9. PubMed ID: 26680925
[TBL] [Abstract][Full Text] [Related]
23. Weekly oxaliplatin, high-dose infusional 5-fluorouracil and folinic acid as palliative third-line therapy of advanced colorectal carcinoma.
Kallen KJ; Hofmann MA; Timm A; Gödderz W; Galle PR; Heike M
Z Gastroenterol; 2000 Feb; 38(2):153-7. PubMed ID: 10721170
[TBL] [Abstract][Full Text] [Related]
24. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
25. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
26. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
27. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.
Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kouroussis Ch; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
J BUON; 2005; 10(1):47-52. PubMed ID: 17335131
[TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin/5-FU without leucovorin chemotherapy in metastatic colorectal cancer.
Shim BY; Lee KM; Cho HM; Kim HJ; Cho HJ; Yang J; Kim JG; Kim HK
Cancer Res Treat; 2005 Aug; 37(4):212-5. PubMed ID: 19956516
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of irinotecan, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as first-line therapy.
Won YW; Lim YH; Park HY; Oh HS; Choi JH; Lee YY; Kim IS; Choi IY; Ahn MJ
Cancer Res Treat; 2004 Aug; 36(4):235-9. PubMed ID: 20368840
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of oxaliplatin, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as second line therapy.
Lee DJ; Oh HS; Choi JH; Lee YY; Kim IS; Ahn MJ
Cancer Res Treat; 2006 Dec; 38(4):201-5. PubMed ID: 19771243
[TBL] [Abstract][Full Text] [Related]
31. Oxaliplatin with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (Modified FOLFOX 4) as first-line therapy for patients with metastatic colorectal cancer.
Kwon HC; Kim KT; Lee SA; Park JS; Kim SH; Kim JS; Kim HJ
Cancer Res Treat; 2004 Apr; 36(2):115-20. PubMed ID: 20396550
[TBL] [Abstract][Full Text] [Related]
32. Combination chemotherapy of oxaliplatin, 5-fluorouracil and low dose leucovorin in patients with advanced colorectal cancer.
Shin YM; Han HS; Lim SW; Kim BC; Cheoi KS; Eum YO; Kim ST; Lee KH
Cancer Res Treat; 2005 Oct; 37(5):284-9. PubMed ID: 19956528
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of a modified chronomodulated infusion of oxaliplatin, 5-fluorouracil and leucovorin in advanced colorectal cancer (preliminary data).
Park JY; Kim SY; Lee JJ; Yoon HJ; Cho KS
Cancer Res Treat; 2004 Jun; 36(3):199-204. PubMed ID: 20396545
[TBL] [Abstract][Full Text] [Related]
34. Pilot Study of Heptaplatin, UFT-E and Leucovorin in Advanced Gastric Carcinoma.
Oh SC; Yoon SY; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim SY; Yoon HJ; Cho KS; Kim JS
Cancer Res Treat; 2003 Apr; 35(2):117-22. PubMed ID: 26680924
[TBL] [Abstract][Full Text] [Related]
35. A Phase II Trial of UFT-E and Oral Leucovorin in Advanced Colorectal Cancer.
Lee WS; Lee KS; Kim KH; Ryoo BY; Kim WS; Kang WK; Kang YK; Heo DS; Bang YJ; Kim NK
Cancer Res Treat; 2001 Jun; 33(3):225-8. PubMed ID: 26680789
[TBL] [Abstract][Full Text] [Related]
36. Double-modulation of 5-Fluorouracil by methotrexate and leucovorin in advanced colorectal-carcinoma.
Leone B; Romero A; Rabinovich M; Vallejo C; Bianco A; Perez J; Rodriguez R; Cuevas M; Machiavelli M; Paris A; Lacava J
Int J Oncol; 1993 Nov; 3(5):995-9. PubMed ID: 21573464
[TBL] [Abstract][Full Text] [Related]
37. Salvage Treatment for Advanced Gastric Cancer Using FEP (5-FU, Etoposide, Cisplatin) Combination Chemotherapy.
Chung JH; Bae YZ; Kim SH; Moon CH; Chung JY; Kwon HC; Kim JS; Kim HJ
Cancer Res Treat; 2002 Oct; 34(5):382-7. PubMed ID: 26680891
[TBL] [Abstract][Full Text] [Related]
38. Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study.
Thuss-Patience PC; von Minckwitz G; Kretzschmar A; Loibl S; Schaller G; Dörken B; Reichardt P
Anticancer Drugs; 2003 Aug; 14(7):549-53. PubMed ID: 12960739
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of oxaliplatin, 5-Fluorouracil, and folinic Acid combination chemotherapy as first-line treatment in metastatic or recurrent gastric cancer.
Kim HJ; Eun JY; Jeon YW; Yun J; Kim KH; Kim SH; Kim HJ; Lee SC; Bae SB; Kim CK; Lee NS; Lee KT; Park SK; Won JH; Hong DS; Park HS
Cancer Res Treat; 2011 Sep; 43(3):154-9. PubMed ID: 22022292
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer.
Cybulska-Stopa B; Ziobro M; Skoczek M; Kojs-Pasińska E; Cedrych I; Brandys A
Contemp Oncol (Pozn); 2013; 17(1):78-82. PubMed ID: 23788967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
